NR. 4/2009



Wizualizacja błony granicznej wewnętrznej (ILM) za pomocą Brilliant Peel® w chirurgii otworów plamki

Internal Limiting Membrane (ILM) Visualization with Brilliant Peel® in the Macular Hole Surgery


Maria Kmera-Muszyńska, Magdalena Ulińska, Małgorzata Wojnarowska-Kucharska

Katedra i Klinika Okulistyki II Wydziału Lekarskiego Warszawskiego Uniwersytetu Medycznego
Samodzielny Publiczny Kliniczny Szpital Okulistyczny w Warszawie
Kierownik: prof. dr hab. n. med. Jerzy Szaflik

Summary: Most vitreo-retinal surgeons use some dyes to visualize internal limiting membrane (ILM) during macular hole and macular pucker surgery. The procedure of tissue dying during vitrectomy is called chromovitrectomy. This technique improves ILM visualization and enables it’s safe peeling.
The aim of the study was to present our own experience with Brilliant Blue G (BBG, Brilliant Peel®) use in ILM dying.
Method: We treated 36 patients with idiopathic macular holes (17 eyes in stage III and 19 in stage IV) in whom we used Brilliant Peel® during vitrectomy to dye ILM. After hyaloid core removal, posterior vitreous detachment was created in cases of its absence. BBG solution (0.25 mg/ 1 ml) was injected into the vitreous cavity and then washed out. We observed very good ILM visualization, which enabled easy and safe ILM removal.
Results: In 91.6% of cases we achieved final closure of macular hole. In 58.3% we observed visual acuity improvement of at least 2 Snellen lines. No adverse effects were observed during follow-up period, which was at least 3 months (ranging between 3 and 12).
Conclusion: We may confirm that Brilliant Peel® is useful and safe in chromovitrectomy for macular hole surgery.
Key words: internal limiting membrane, chromovitrectomy, Brilliant Blue G (Brilliant Peel®), macular holes.
Słowa kluczowe:  błona graniczna wewnętrzna, chromowitrektomia, błękit brylantowy G (Brilliant Peel®), otwory plamki.



linia-lewa.gif (150 bytes)


Redakcja kwartalnika medycznego "Okulistyka"
Oftal Sp. z o.o.
tel./fax: (0-22) 670-47-40
centrala: (0-22) 618-84-85 wew. 52-45
03-709 Warszawa ul. Sierakowskiego 13 (Szpital)


Redakcja ored@okulistyka.com.pl